These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8797479

  • 1. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam.
    Chen X, Xia Y, Gresham LS, Molgaard CA, Thomas RG, Galasko D, Wiederholt WC, Saitoh T.
    Neurology; 1996 Sep; 47(3):779-84. PubMed ID: 8797479
    [Abstract] [Full Text] [Related]

  • 2. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
    Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AF, Edwardson JA, Daly AK, Morris CM.
    Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes.
    Buée L, Pérez-Tur J, Leveugle B, Buée-Scherrer V, Mufson EJ, Loerzel AJ, Chartier-Harlin MC, Perl DP, Delacourte A, Hof PR.
    Acta Neuropathol; 1996 Feb; 91(3):247-53. PubMed ID: 8834536
    [Abstract] [Full Text] [Related]

  • 4. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
    Gołab-Janowska M, Honczarenko K, Gawrońska-Szklarz B, Potemkowski A.
    Neurol Neurochir Pol; 2007 Feb; 41(2):113-21. PubMed ID: 17530572
    [Abstract] [Full Text] [Related]

  • 5. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
    Bon MA, Jansen Steur EN, de Vos RA, Vermes I.
    Neurosci Lett; 1999 May 07; 266(2):149-51. PubMed ID: 10353349
    [Abstract] [Full Text] [Related]

  • 6. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.
    Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK, Chapman NH, Anderson L, Bird TD, Plato CC, Perl DP, Weiderholt W, Galasko D, Schellenberg GD.
    Arch Neurol; 2001 Nov 07; 58(11):1871-8. PubMed ID: 11708997
    [Abstract] [Full Text] [Related]

  • 7. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Mawal-Dewan M, Schmidt ML, Balin B, Perl DP, Lee VM, Trojanowski JQ.
    J Neuropathol Exp Neurol; 1996 Oct 07; 55(10):1051-9. PubMed ID: 8858002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.
    Maraganore DM, Farrer MJ, Hardy JA, McDonnell SK, Schaid DJ, Rocca WA.
    Mov Disord; 2000 Jul 07; 15(4):714-9. PubMed ID: 10928584
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Waring SC, O'Brien PC, Kurland LT, Thibodeau SN, Tsai MS, Petersen RC, Esteban-Santillan CE.
    Lancet; 1994 Mar 05; 343(8897):611. PubMed ID: 7906373
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.